Immuntherapie gegen Gliome: Leitthema
Background Gliomas represent the most frequent malignant primary brain tumors in adults. Despite multimodal treatment concepts involving surgery, irradiation and chemotherapy, the prognosis remains poor and they are incurable. Recent insights into the interactions between the immune system and the c...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Deutsch |
| Veröffentlicht: |
February 2024
|
| In: |
Der Nervenarzt
Year: 2024, Jahrgang: 95, Heft: 2, Pages: 111-116 |
| ISSN: | 1433-0407 |
| DOI: | 10.1007/s00115-023-01590-5 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00115-023-01590-5 Verlag, kostenfrei, Volltext: http://link.springer.com/article/10.1007/s00115-023-01590-5 
|
| Verfasserangaben: | Katharina Sahm, Tobias Weiss |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1919959750 | ||
| 003 | DE-627 | ||
| 005 | 20250717001706.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250318s2024 xx |||||o 00| ||ger c | ||
| 024 | 7 | |a 10.1007/s00115-023-01590-5 |2 doi | |
| 035 | |a (DE-627)1919959750 | ||
| 035 | |a (DE-599)KXP1919959750 | ||
| 035 | |a (OCoLC)1528043291 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a ger | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Sahm, Katharina |d 1985- |e VerfasserIn |0 (DE-588)1048541762 |0 (DE-627)780594371 |0 (DE-576)402374452 |4 aut | |
| 245 | 1 | 0 | |a Immuntherapie gegen Gliome |b Leitthema |c Katharina Sahm, Tobias Weiss |
| 246 | 1 | |i Englischsprachige Zusammenfassung unter dem Titel |a Immunotherapy against gliomas | |
| 264 | 1 | |c February 2024 | |
| 300 | |b Illustrationen | ||
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online veröffentlicht: 02. Januar 2024 | ||
| 500 | |a Gesehen am 18.03.2025 | ||
| 520 | |a Background Gliomas represent the most frequent malignant primary brain tumors in adults. Despite multimodal treatment concepts involving surgery, irradiation and chemotherapy, the prognosis remains poor and they are incurable. Recent insights into the interactions between the immune system and the central nervous system as well as breakthroughs in the results of other cancer types have led to the fact that various immunotherapeutic approaches against gliomas have also been investigated and in some cases specifically developed. Objective This article provides an overview of the current status of different immunotherapeutic concepts against gliomas, highlighting the advantages, disadvantages, and challenges. Additionally, it provides an overview of currently ongoing immunotherapeutic clinical trials in Germany and neighboring countries. Results Previous randomized studies on antibodies against programmed cell death protein 1 (anti-PD1) immune checkpoint inhibition, viral treatment and peptide vaccination targeting the variant III of the epidermal growth factor receptor (EGFRvIII) in glioblastomas were negative with respect to survival benefits. Conversely, other immunotherapeutic approaches, such as multivalent or driver mutation-based vaccinations, cytokine-based therapy and cell therapy, demonstrated a robust scientific foundation, with at least early studies showing promising safety and pharmacodynamic effects on the tumors. Discussion Currently, immunotherapies against gliomas should only be applied within the framework of well-designed clinical studies. There are still many knowledge gaps regarding the mechanisms of action and resistance of various immunotherapies. Accompanying translational research is essential to address these gaps and develop more effective therapies. | ||
| 546 | |a Sprache der Zusammenfassungen: Deutsch und Englisch | ||
| 700 | 1 | |a Weiss, Tobias |d 1984- |e VerfasserIn |0 (DE-588)1203001533 |0 (DE-627)1687681392 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Der Nervenarzt |d Berlin : Springer, 1996 |g 95(2024), 2 vom: Feb., Seite 111-116 |h Online-Ressource |w (DE-627)25463835X |w (DE-600)1462945-8 |w (DE-576)074531468 |x 1433-0407 |7 nnas |a Immuntherapie gegen Gliome Leitthema |
| 773 | 1 | 8 | |g volume:95 |g year:2024 |g number:2 |g month:02 |g pages:111-116 |g extent:6 |a Immuntherapie gegen Gliome Leitthema |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00115-023-01590-5 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://link.springer.com/article/10.1007/s00115-023-01590-5 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250318 | ||
| 993 | |a Article | ||
| 994 | |a 2024 | ||
| 998 | |g 1048541762 |a Sahm, Katharina |m 1048541762:Sahm, Katharina |d 60000 |d 62700 |e 60000PS1048541762 |e 62700PS1048541762 |k 0/60000/ |k 1/60000/62700/ |p 1 |x j | ||
| 999 | |a KXP-PPN1919959750 |e 4687855296 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Online veröffentlicht: 02. Januar 2024","Gesehen am 18.03.2025"],"id":{"doi":["10.1007/s00115-023-01590-5"],"eki":["1919959750"]},"recId":"1919959750","person":[{"display":"Sahm, Katharina","role":"aut","family":"Sahm","given":"Katharina"},{"display":"Weiss, Tobias","given":"Tobias","family":"Weiss","role":"aut"}],"title":[{"subtitle":"Leitthema","title":"Immuntherapie gegen Gliome","title_sort":"Immuntherapie gegen Gliome"}],"physDesc":[{"noteIll":"Illustrationen","extent":"6 S."}],"name":{"displayForm":["Katharina Sahm, Tobias Weiss"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Immuntherapie gegen Gliome LeitthemaDer Nervenarzt","title":[{"subtitle":"Organ der Deutschen Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde ; Mitteilungsblatt der Deutschen Gesellschaft für Neurologie","title":"Der Nervenarzt","title_sort":"Nervenarzt"}],"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 18.10.06","Ungezählte Beil.: Supplement"],"id":{"issn":["1433-0407"],"eki":["25463835X"],"zdb":["1462945-8"]},"recId":"25463835X","pubHistory":["Nachgewiesen 67.1996,8 -"],"titleAlt":[{"title":"Organ von: Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde ; Mitteilungsblatt von: Deutsche Gesellschaft für Neurologie, Gesellschaft Österreichischer Nervenärzte und Psychiater ; begründet 1928"}],"language":["ger"],"origin":[{"dateIssuedKey":"1996","publisherPlace":"Berlin ; Heidelberg ; Berlin ; Heidelberg ; New York, NY","dateIssuedDisp":"1996-","publisher":"Springer ; Springer"}],"part":{"volume":"95","text":"95(2024), 2 vom: Feb., Seite 111-116","extent":"6","pages":"111-116","issue":"2","year":"2024"}}],"titleAlt":[{"title":"Immunotherapy against gliomas"}],"language":["ger"],"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"February 2024"}]} | ||
| SRT | |a SAHMKATHARIMMUNTHERA2024 | ||